Machine-Learning-Assisted Microfluidic Nanoplasmonic Digital Immunoassay for Cytokine Storm Profiling in COVID-19 Patients

Abstract

Cytokine storm, known as an exaggerated hyperactive immune response characterized by elevated release of cytokines, has been described as a feature associated with life-threatening complications in COVID-19 patients. A critical evaluation of a cytokine storm and its mechanistic linkage to COVID-19 requires innovative immunoassay technology capable of rapid, sensitive, selective detection of multiple cytokines across a wide dynamic range at high-throughput. In this study, we report a machine-learning-assisted microfluidic nanoplasmonic digital immunoassay to meet the rising demand for cytokine storm monitoring in COVID-19 patients. Specifically, the assay was carried out using a facile one-step sandwich immunoassay format with three notable features: (i) a microfluidic microarray patterning technique for high-throughput, multiantibody-arrayed biosensing chip fabrication; (ii) an ultrasensitive nanoplasmonic digital imaging technology utilizing 100 nm silver nanocubes (AgNCs) for signal transduction; (iii) a rapid and accurate machine-learning-based image processing method for digital signal analysis. The developed immunoassay allows simultaneous detection of six cytokines in a single run with wide working ranges of 1–10,000 pg mL–1 and ultralow detection limits down to 0.46–1.36 pg mL–1 using a minimum of 3 μL serum samples. The whole chip can afford a 6-plex assay of 8 different samples with 6 repeats in each sample for a total of 288 sensing spots in less than 100 min. The image processing method enhanced by convolutional neural network (CNN) dramatically shortens the processing time ∼6,000 fold with a much simpler procedure while maintaining high statistical accuracy compared to the conventional manual counting approach. The immunoassay was validated by the gold-standard enzyme-linked immunosorbent assay (ELISA) and utilized for serum cytokine profiling of COVID-19 positive patients. Our results demonstrate the nanoplasmonic digital immunoassay as a promising practical tool for comprehensive characterization of cytokine storm in patients that holds great promise as an intelligent immunoassay for next generation immune monitoring.

Noble Metal Nanoparticles for Point-of-Care Testing: Recent Advancements and Social Impacts

“…The knowledge of other disciplines can be used to maximize the capability of NM NPs-based POC tests. For example, machine-learning-based image processing method was used for digital signal analysis in an Ag NP-based plasmonic biosensor [ 109 ]. Compared to conventional image processing methods, machine-learning-based image processing is more rapid and accurate, making it suitable for rapid and high-throughput detection.…”

Merging microfluidics with luminescence immunoassays for urgent point-of-care diagnostics of COVID-19

“…Excitingly, the emerging novel enzyme and nucleic acid-based signal enhancement strategies have significantly improved analytical performance of luminescence immunoassays, such as polymerized catecholamines depositing around HRP for cascade amplification [ 375 , 376 ], nucleic acid chains as labels for amplification [ [377] , [378] , [379] , [380] , [381] ], fluorescent-labeled aptamers based thermophoretic enrichment assays [ 192 , [382] , [383] , [384] , [385] , [386] ] and clustered regularly interspaced short palindromic repeat (CRISPR) based amplification [ 387 , 388 ]. In addition to methodology, the other perspective is miniaturization of equipment and intellectualization of performance, benefiting from the rapid development of the Internet, such as smartphones and 5G technology [ 313 , 331 , [389] , [390] , [391] , [392] , [393] ]. Finally, other than endpoint testing, real-time detecting systems, such as wearable devices, with continuous monitoring of processes can better meet the needs for POCTs on the progress of the immune response [ [394] , [395] , [396] , [397] , [398] ].…”

Microfluidics Technology in SARS-CoV-2 Diagnosis and Beyond: A Systematic Review

“…The assay measured six cytokines in these samples, and the results showed elevated serum cytokine levels in these patients. On further serum cytokine profiling from different patients, the immunoassay presented high sensitivity, precision, and wide dynamic range in serum cytokine assessment [ 134 ].…”